董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Bruce T. Bernstein | 男 | Chairman of the Board | 61 | 30.66万美元 | 64.69 | 2025-12-18 |
| Robert Weinstein | 男 | Independent Director | 66 | 11.43万美元 | 38.65 | 2025-12-18 |
| Michael Lebowitz | 男 | Independent Director | 53 | 9.46万美元 | 36.29 | 2025-12-18 |
| Ezra T. Ernst | 男 | President & Chief Executive Officer and Director | 56 | 49.57万美元 | 21.80 | 2025-12-18 |
| Galle Wizenberg | 女 | Independent Director | 50 | 8.01万美元 | 31.06 | 2025-12-18 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Ezra T. Ernst | 男 | President & Chief Executive Officer and Director | 56 | 49.57万美元 | 21.80 | 2025-12-18 |
| Thomas Ian Brown | 男 | Chief Financial Officer | 55 | 46.71万美元 | 3.70 | 2025-12-18 |
董事简历
中英对照 | 中文 | 英文- Bruce T. Bernstein
-
Bruce T. Bernstein于2020年加入Petros担任董事。Bernstein先生于2016年至2020年担任Neurotrope的董事会成员，目前担任Synaptogenix, Inc.的董事会成员，Synaptogenix, Inc.是Neurotrope的运营子公司，Neurotrope于2020年12月从Neurotrope分拆出来。Bernstein先生在证券行业拥有30多年的经验，主要担任两个另类金融基金的高级投资组合经理，以及套利策略的交易和结构设计。Bernstein先生自2006年起担任Rockmore Capital，LLC的总裁，该公司是一家直接投资和贷款基金的经理，管理的最高资产为1.4亿美元。此前，他曾担任Omicron Capital，LP的联席总裁，该公司是一家位于纽约的投资公司，他于2001年加入该公司。Omicron Capital专注于对上市小型股公司的直接投资和贷款，管理的最高资产为2.6亿美元。在加入Omicron Capital之前，Bernstein先生曾任职于富通投资公司，担任该银行全球证券套利业务部高级副总裁，专门研究股票结构性产品和股票套利，之后担任该银行美国自营投资业务总裁。在加入海富通之前，Bernstein先生是野村证券国际公司股票衍生产品组的主管，专门从事跨境税收套利、国内股票套利和结构性股票互换。Bernstein的职业生涯始于Kidder Peabody，后来升至助理财务主管。Bernstein先生还担任XpresSpa控股公司的董事会成员，该公司是总部设在纽约的世界领先的机场水疗公司。Bernstein先生还是Summit Digital Health的董事会成员，Summit Digital Health是一家总部位于新泽西州的激光血糖监测仪分销商。Bernstein先生拥有纽约城市大学（Baruch）的学士学位。
Bruce T. Bernstein served as a Director for Neurotrope since November 14, 2016 and has been vice chairman of the Board of TAO Synergies since October, 2025. Mr. Bernstein has over thirty years of experience in the securities industry, primarily as senior portfolio manager for two alternative finance funds as well as in trading and structuring of arbitrage strategies. Mr. Bernstein has served as President of Rockmore Capital, LLC since 2006, the manager of a direct investment and lending fund with peak assets under management of $140 million. Previously, he served as Co President of Omicron Capital, LP, an investment firm based in New York, which he joined in 2001. Omicron Capital focused on direct investing and lending to public small cap companies and had peak assets under management of $260 million. Prior to joining Omicron Capital, Mr. Bernstein was with Fortis Investments Inc., where he was Senior Vice President in the bank's Global Securities Arbitrage business unit, specializing in equity structured products and equity arbitrage and then President in charge of the bank's proprietary investment business in the United States. Prior to Fortis, Mr. Bernstein was Director in the Equity Derivatives Group at Nomura Securities International specializing in cross border tax arbitrage, domestic equity arbitrage and structured equity swaps. Mr. Bernstein started his career at Kidder Peabody, where he rose to the level of Assistant Treasurer. Mr. Bernstein also serves as a member of the Board of Directors of XWELL, Inc., the leading airport spa company in the world, based in New York and Petros Pharmaceuticals, Inc. Mr. Bernstein is also a member of the board of Wrap Technologies Inc., a provider of public safety technology and services, based in Florida. Mr. Bernstein holds a B.B.A. from City University of New York (Baruch). - Bruce T. Bernstein于2020年加入Petros担任董事。Bernstein先生于2016年至2020年担任Neurotrope的董事会成员，目前担任Synaptogenix, Inc.的董事会成员，Synaptogenix, Inc.是Neurotrope的运营子公司，Neurotrope于2020年12月从Neurotrope分拆出来。Bernstein先生在证券行业拥有30多年的经验，主要担任两个另类金融基金的高级投资组合经理，以及套利策略的交易和结构设计。Bernstein先生自2006年起担任Rockmore Capital，LLC的总裁，该公司是一家直接投资和贷款基金的经理，管理的最高资产为1.4亿美元。此前，他曾担任Omicron Capital，LP的联席总裁，该公司是一家位于纽约的投资公司，他于2001年加入该公司。Omicron Capital专注于对上市小型股公司的直接投资和贷款，管理的最高资产为2.6亿美元。在加入Omicron Capital之前，Bernstein先生曾任职于富通投资公司，担任该银行全球证券套利业务部高级副总裁，专门研究股票结构性产品和股票套利，之后担任该银行美国自营投资业务总裁。在加入海富通之前，Bernstein先生是野村证券国际公司股票衍生产品组的主管，专门从事跨境税收套利、国内股票套利和结构性股票互换。Bernstein的职业生涯始于Kidder Peabody，后来升至助理财务主管。Bernstein先生还担任XpresSpa控股公司的董事会成员，该公司是总部设在纽约的世界领先的机场水疗公司。Bernstein先生还是Summit Digital Health的董事会成员，Summit Digital Health是一家总部位于新泽西州的激光血糖监测仪分销商。Bernstein先生拥有纽约城市大学（Baruch）的学士学位。
- Bruce T. Bernstein served as a Director for Neurotrope since November 14, 2016 and has been vice chairman of the Board of TAO Synergies since October, 2025. Mr. Bernstein has over thirty years of experience in the securities industry, primarily as senior portfolio manager for two alternative finance funds as well as in trading and structuring of arbitrage strategies. Mr. Bernstein has served as President of Rockmore Capital, LLC since 2006, the manager of a direct investment and lending fund with peak assets under management of $140 million. Previously, he served as Co President of Omicron Capital, LP, an investment firm based in New York, which he joined in 2001. Omicron Capital focused on direct investing and lending to public small cap companies and had peak assets under management of $260 million. Prior to joining Omicron Capital, Mr. Bernstein was with Fortis Investments Inc., where he was Senior Vice President in the bank's Global Securities Arbitrage business unit, specializing in equity structured products and equity arbitrage and then President in charge of the bank's proprietary investment business in the United States. Prior to Fortis, Mr. Bernstein was Director in the Equity Derivatives Group at Nomura Securities International specializing in cross border tax arbitrage, domestic equity arbitrage and structured equity swaps. Mr. Bernstein started his career at Kidder Peabody, where he rose to the level of Assistant Treasurer. Mr. Bernstein also serves as a member of the Board of Directors of XWELL, Inc., the leading airport spa company in the world, based in New York and Petros Pharmaceuticals, Inc. Mr. Bernstein is also a member of the board of Wrap Technologies Inc., a provider of public safety technology and services, based in Florida. Mr. Bernstein holds a B.B.A. from City University of New York (Baruch).
- Robert Weinstein
-
Robert Weinstein于2020年2月加入我们的董事会。Weinstein先生拥有30多年的丰富会计和财务经验，担任公共会计师、投资银行家、梦百合私募股权基金负责人和首席财务官。自2013年10月以来，韦恩斯坦一直担任生物技术上市公司Neurotrope，Inc.（McKinsey）的首席财务官。2011年9月至2013年9月，韦恩斯坦先生是制药和生物技术行业几家梦百合公司的独立顾问。Weinstein从2010年3月到2011年8月担任Green Energy Management Services Holdings，Inc.（一家上市能源咨询公司）首席财务官。2007年8月至2010年2月，Weinstein先生担任Xcorporeal，Inc.的首席财务官，该公司是一家上市的处于发展阶段的医疗设备公司，于2010年3月出售给Fresenius Medical USA，后者是全球最大的透析设备和服务提供商。Weinstein先生在芝加哥大学商学院（University of Chicago Graduate School of Business）获得金融与国际商务工商管理硕士学位，是一名不活跃的注册会计师，并在纽约州立大学奥尔巴尼分校（State University of New York at Albany）获得会计学学士学位。
Robert Weinstein has served as a director of the Company since November 2022. Mr. Weinstein has served as chief financial officer of TAO Synergies Inc. (formerly Synaptogenix, Inc.) (Nasdaq: TAOX) since October 2013. In addition, Mr. Weinstein performs work as a consultant for Petros Pharmaceuticals, Inc. (Nasdaq: PTPI) and Fabric AI, Inc. (Nasdaq: FABC). He has extensive accounting and finance experience, spanning more than 40 years, as a public accountant, investment banker, healthcare private equity fund principal and chief financial officer. From September 2011 to the present, Mr. Weinstein has also been an independent consultant for several healthcare companies in the pharmaceutical and biotechnology industries. Mr. Weinstein also serves as a member of the Board of Directors of XWELL, Inc. (formerly XpresSpa Group, Inc.) (Nasdaq: XWEL), a health and wellness company whose core assets, XpresSpa and XpresCheck, is a leading airport retailer of spa services and related health and wellness products. Mr. Weinstein received his MBA degree in finance and international business from the University of Chicago Graduate School of Business, is a Certified Public Accountant (inactive), and received his BS degree in accounting from the State University of New York at Albany. Mr. Weinstein was chosen as a director of the Company because of his public company and financial expertise. - Robert Weinstein于2020年2月加入我们的董事会。Weinstein先生拥有30多年的丰富会计和财务经验，担任公共会计师、投资银行家、梦百合私募股权基金负责人和首席财务官。自2013年10月以来，韦恩斯坦一直担任生物技术上市公司Neurotrope，Inc.（McKinsey）的首席财务官。2011年9月至2013年9月，韦恩斯坦先生是制药和生物技术行业几家梦百合公司的独立顾问。Weinstein从2010年3月到2011年8月担任Green Energy Management Services Holdings，Inc.（一家上市能源咨询公司）首席财务官。2007年8月至2010年2月，Weinstein先生担任Xcorporeal，Inc.的首席财务官，该公司是一家上市的处于发展阶段的医疗设备公司，于2010年3月出售给Fresenius Medical USA，后者是全球最大的透析设备和服务提供商。Weinstein先生在芝加哥大学商学院（University of Chicago Graduate School of Business）获得金融与国际商务工商管理硕士学位，是一名不活跃的注册会计师，并在纽约州立大学奥尔巴尼分校（State University of New York at Albany）获得会计学学士学位。
- Robert Weinstein has served as a director of the Company since November 2022. Mr. Weinstein has served as chief financial officer of TAO Synergies Inc. (formerly Synaptogenix, Inc.) (Nasdaq: TAOX) since October 2013. In addition, Mr. Weinstein performs work as a consultant for Petros Pharmaceuticals, Inc. (Nasdaq: PTPI) and Fabric AI, Inc. (Nasdaq: FABC). He has extensive accounting and finance experience, spanning more than 40 years, as a public accountant, investment banker, healthcare private equity fund principal and chief financial officer. From September 2011 to the present, Mr. Weinstein has also been an independent consultant for several healthcare companies in the pharmaceutical and biotechnology industries. Mr. Weinstein also serves as a member of the Board of Directors of XWELL, Inc. (formerly XpresSpa Group, Inc.) (Nasdaq: XWEL), a health and wellness company whose core assets, XpresSpa and XpresCheck, is a leading airport retailer of spa services and related health and wellness products. Mr. Weinstein received his MBA degree in finance and international business from the University of Chicago Graduate School of Business, is a Certified Public Accountant (inactive), and received his BS degree in accounting from the State University of New York at Albany. Mr. Weinstein was chosen as a director of the Company because of his public company and financial expertise.
- Michael Lebowitz
-
Michael Lebowitz于2020年4月加入我们的董事会。Lebowitz先生是客户体验战略和创新方面的专家，在为世界上一些最知名的品牌定义创意战略和愿景方面有着25年的历史。Lebowitz先生于2000年创立了Big Spachip，这是一家全球公认的创意咨询公司，并自Big Spachip成立以来担任其首席执行官。Lebowitz先生在瓦萨学院（Vassar College）获得电影学士学位。
Michael Lebowitz in ctomer experience strategy and innovation, Mr. Lebowitz has a tnty five year track record in defining creative strategy and vision for some of the world's most recognizable brands. Mr. Lebowitz founded Big Spaceship, a globally recognized creative consultancy, in 2000 and has served as Chief Executive Officer of Big Spaceship since its founding. Mr. Lebowitz received his Bachelor's degree in Film from Vassar College. - Michael Lebowitz于2020年4月加入我们的董事会。Lebowitz先生是客户体验战略和创新方面的专家，在为世界上一些最知名的品牌定义创意战略和愿景方面有着25年的历史。Lebowitz先生于2000年创立了Big Spachip，这是一家全球公认的创意咨询公司，并自Big Spachip成立以来担任其首席执行官。Lebowitz先生在瓦萨学院（Vassar College）获得电影学士学位。
- Michael Lebowitz in ctomer experience strategy and innovation, Mr. Lebowitz has a tnty five year track record in defining creative strategy and vision for some of the world's most recognizable brands. Mr. Lebowitz founded Big Spaceship, a globally recognized creative consultancy, in 2000 and has served as Chief Executive Officer of Big Spaceship since its founding. Mr. Lebowitz received his Bachelor's degree in Film from Vassar College.
- Ezra T. Ernst
-
Ezra T. Ernst自2022年1月收购GCG Connect LLC d/b/a HyperPointe起担任公司执行副总裁兼子公司XpreSTest，Inc.首席执行官。他还自2020年3月起担任HyperPointe总裁兼首席执行官。在加入HyperPointe之前，他曾于2015年8月至2020年3月担任为医疗保健专业人员提供医疗新闻和教育的Physicians ekly，LLC的首席执行官，2013年9月至2015年8月担任健康相关数据分析公司Treato的首席商务官，并于2008年12月至2013年1月担任健康和医疗新闻和信息在线出版商bMD的总经理。
Ezra T. Ernst served as Executive Vice President of the Company and Chief Executive Officer of subsidiary XpresTest, Inc. since January 2022 acquisition of gcg Connect LLC d/b/a HyperPointe. He also has served as President and Chief Executive Officer of HyperPointe since March 2020. Prior to HyperPointe, he previoly served as Chief Executive Officer of Physicians ekly, LLC, a provider of medical news and education for healthcare professionals, from August 2015 to March 2020, chief Commercial Officer of Treato, a health related data analytics company, from September 2013 to August 2015 and General Manager at bMD, an online publisher of health and medical news and information, from December 2008 to January 2013. - Ezra T. Ernst自2022年1月收购GCG Connect LLC d/b/a HyperPointe起担任公司执行副总裁兼子公司XpreSTest，Inc.首席执行官。他还自2020年3月起担任HyperPointe总裁兼首席执行官。在加入HyperPointe之前，他曾于2015年8月至2020年3月担任为医疗保健专业人员提供医疗新闻和教育的Physicians ekly，LLC的首席执行官，2013年9月至2015年8月担任健康相关数据分析公司Treato的首席商务官，并于2008年12月至2013年1月担任健康和医疗新闻和信息在线出版商bMD的总经理。
- Ezra T. Ernst served as Executive Vice President of the Company and Chief Executive Officer of subsidiary XpresTest, Inc. since January 2022 acquisition of gcg Connect LLC d/b/a HyperPointe. He also has served as President and Chief Executive Officer of HyperPointe since March 2020. Prior to HyperPointe, he previoly served as Chief Executive Officer of Physicians ekly, LLC, a provider of medical news and education for healthcare professionals, from August 2015 to March 2020, chief Commercial Officer of Treato, a health related data analytics company, from September 2013 to August 2015 and General Manager at bMD, an online publisher of health and medical news and information, from December 2008 to January 2013.
- Galle Wizenberg
-
Ga lle Wizenberg，于2024年10月创立Objects of Magic SAV de CV，2022年8月创立Objects of Magic LLC，这是一个提供全线产品、团队建设和健康静修的健康品牌，她自公司成立以来一直担任首席执行官。此前，她于2019年7月创立咨询公司Charlie Banana Consulting，LLC，并于2019年7月至2025年3月担任董事兼首席执行官。此外，她于2013年创立了全球品牌婴儿用品的美国电子商务公司Charlie Banana USA，LLC，并担任首席执行官，直到2020年被宝洁公司收购。在跨国消费品公司宝洁收购了她所有的公司后，维岑贝格女士于2020年1月至2023年6月开始为宝洁提供咨询服务。在此之前，Wizenberg女士于2007年创立了Winc Design Limited，这是一家香港公司，是一家环保产品制造商，也是一家全球布尿布制造商，并担任首席执行官至2020年。
Galle Wizenberg An expert in branding, manufacturing, global distribution of consumer goods and serial entrepreneur, Ms. Wizenberg founded Objects of Magic SAV de CV in October 2024, Objects of Magic LLC, a llness brand offering a full line of products, team building and llness retreats, in Augt 2022, and she has served as Chief Executive Officer since the founding of the company. Prior to this, she founded Charlie Banana Consulting, LLC, a consulting firm, in July 2019 and served as Director and Chief Executive Officer from July 2019 to March 2025. Additionally, she founded Charlie Banana A, LLC, a A based ecommerce of global brand baby products in 2013 and served as Chief Executive Officer until 2020 when it was acquired by Proctor & Gamble. After Proctor & Gamble, a multinational consumer goods corporation, acquired all her companies, Ms. Wizenberg began consulting for Procter & Gamble from January 2020 to June 2023. Before that, Ms. Wizenberg founded Winc Design Limited, a Hong Kong company, makers of ecofriendly products and a global cloth diaper manufacturer, in 2007 and served as CEO until 2020. - Ga lle Wizenberg，于2024年10月创立Objects of Magic SAV de CV，2022年8月创立Objects of Magic LLC，这是一个提供全线产品、团队建设和健康静修的健康品牌，她自公司成立以来一直担任首席执行官。此前，她于2019年7月创立咨询公司Charlie Banana Consulting，LLC，并于2019年7月至2025年3月担任董事兼首席执行官。此外，她于2013年创立了全球品牌婴儿用品的美国电子商务公司Charlie Banana USA，LLC，并担任首席执行官，直到2020年被宝洁公司收购。在跨国消费品公司宝洁收购了她所有的公司后，维岑贝格女士于2020年1月至2023年6月开始为宝洁提供咨询服务。在此之前，Wizenberg女士于2007年创立了Winc Design Limited，这是一家香港公司，是一家环保产品制造商，也是一家全球布尿布制造商，并担任首席执行官至2020年。
- Galle Wizenberg An expert in branding, manufacturing, global distribution of consumer goods and serial entrepreneur, Ms. Wizenberg founded Objects of Magic SAV de CV in October 2024, Objects of Magic LLC, a llness brand offering a full line of products, team building and llness retreats, in Augt 2022, and she has served as Chief Executive Officer since the founding of the company. Prior to this, she founded Charlie Banana Consulting, LLC, a consulting firm, in July 2019 and served as Director and Chief Executive Officer from July 2019 to March 2025. Additionally, she founded Charlie Banana A, LLC, a A based ecommerce of global brand baby products in 2013 and served as Chief Executive Officer until 2020 when it was acquired by Proctor & Gamble. After Proctor & Gamble, a multinational consumer goods corporation, acquired all her companies, Ms. Wizenberg began consulting for Procter & Gamble from January 2020 to June 2023. Before that, Ms. Wizenberg founded Winc Design Limited, a Hong Kong company, makers of ecofriendly products and a global cloth diaper manufacturer, in 2007 and served as CEO until 2020.
高管简历
中英对照 | 中文 | 英文- Ezra T. Ernst
Ezra T. Ernst自2022年1月收购GCG Connect LLC d/b/a HyperPointe起担任公司执行副总裁兼子公司XpreSTest，Inc.首席执行官。他还自2020年3月起担任HyperPointe总裁兼首席执行官。在加入HyperPointe之前，他曾于2015年8月至2020年3月担任为医疗保健专业人员提供医疗新闻和教育的Physicians ekly，LLC的首席执行官，2013年9月至2015年8月担任健康相关数据分析公司Treato的首席商务官，并于2008年12月至2013年1月担任健康和医疗新闻和信息在线出版商bMD的总经理。
Ezra T. Ernst served as Executive Vice President of the Company and Chief Executive Officer of subsidiary XpresTest, Inc. since January 2022 acquisition of gcg Connect LLC d/b/a HyperPointe. He also has served as President and Chief Executive Officer of HyperPointe since March 2020. Prior to HyperPointe, he previoly served as Chief Executive Officer of Physicians ekly, LLC, a provider of medical news and education for healthcare professionals, from August 2015 to March 2020, chief Commercial Officer of Treato, a health related data analytics company, from September 2013 to August 2015 and General Manager at bMD, an online publisher of health and medical news and information, from December 2008 to January 2013.- Ezra T. Ernst自2022年1月收购GCG Connect LLC d/b/a HyperPointe起担任公司执行副总裁兼子公司XpreSTest，Inc.首席执行官。他还自2020年3月起担任HyperPointe总裁兼首席执行官。在加入HyperPointe之前，他曾于2015年8月至2020年3月担任为医疗保健专业人员提供医疗新闻和教育的Physicians ekly，LLC的首席执行官，2013年9月至2015年8月担任健康相关数据分析公司Treato的首席商务官，并于2008年12月至2013年1月担任健康和医疗新闻和信息在线出版商bMD的总经理。
- Ezra T. Ernst served as Executive Vice President of the Company and Chief Executive Officer of subsidiary XpresTest, Inc. since January 2022 acquisition of gcg Connect LLC d/b/a HyperPointe. He also has served as President and Chief Executive Officer of HyperPointe since March 2020. Prior to HyperPointe, he previoly served as Chief Executive Officer of Physicians ekly, LLC, a provider of medical news and education for healthcare professionals, from August 2015 to March 2020, chief Commercial Officer of Treato, a health related data analytics company, from September 2013 to August 2015 and General Manager at bMD, an online publisher of health and medical news and information, from December 2008 to January 2013.
- Thomas Ian Brown
Thomas Ian Brown，拥有系统改造、财务运营和后台流程改进方面的专业知识。从2022年到2025年，布朗先生是Accordion战略FP & A集团的董事总经理。在担任该职务之前，他于2014年至2022年在FTI咨询的技术改造组任职。在此之前，他是Charter通信业务规划、客户运营高级总监，以及Insight Communications运营财务总监。此前，Ian是两家早期公司的CFO，是Ezra Ernst在Wolters Kluwer的同事，也曾在媒体投行工作。他拥有达特茅斯大学塔克商学院的工商管理硕士学位和瓦萨学院的学士学位。
Thomas Ian Brown has more than 25 years of experience in operational finance. He has expertise in systems transformation, financial operations, and back office process improvement. From 2022 to 2025, Mr. Brown was a Managing Director of the Strategic FP&A Group at Accordion. Prior to that role, he served at FTI Consulting in their Technology Transformation group from 2014 to 2022. Prior, he was Senior Director Biness Planning, Ctomer Operations at Charter Communications, and a Director of Operational Finance for Insight Communications. Before this, Ian was the CFO of two early stage companies, was a colleague of Ezra Ernst at Wolters Klur, and also worked in media investment banking. He holds an M.B.A from The Tuck School of Biness at Dartmouth and a B.A. from Vassar College.- Thomas Ian Brown，拥有系统改造、财务运营和后台流程改进方面的专业知识。从2022年到2025年，布朗先生是Accordion战略FP & A集团的董事总经理。在担任该职务之前，他于2014年至2022年在FTI咨询的技术改造组任职。在此之前，他是Charter通信业务规划、客户运营高级总监，以及Insight Communications运营财务总监。此前，Ian是两家早期公司的CFO，是Ezra Ernst在Wolters Kluwer的同事，也曾在媒体投行工作。他拥有达特茅斯大学塔克商学院的工商管理硕士学位和瓦萨学院的学士学位。
- Thomas Ian Brown has more than 25 years of experience in operational finance. He has expertise in systems transformation, financial operations, and back office process improvement. From 2022 to 2025, Mr. Brown was a Managing Director of the Strategic FP&A Group at Accordion. Prior to that role, he served at FTI Consulting in their Technology Transformation group from 2014 to 2022. Prior, he was Senior Director Biness Planning, Ctomer Operations at Charter Communications, and a Director of Operational Finance for Insight Communications. Before this, Ian was the CFO of two early stage companies, was a colleague of Ezra Ernst at Wolters Klur, and also worked in media investment banking. He holds an M.B.A from The Tuck School of Biness at Dartmouth and a B.A. from Vassar College.